<DOC>
	<DOCNO>NCT01980836</DOCNO>
	<brief_summary>Patients rheumatoid arthritis ( RA ) prone respiratory infection therefore recommmended receive vaccination seasonal influenza . We others show relatively preserved humoral response vaccination RA patient . However , cellular response well effect biologics tocilizumab cellular response weel study . The purpose study evaluate effect tocilizumab cellular immune response influenza vaccine patient RA comparison healthy control</brief_summary>
	<brief_title>Effect Tocilizumab Cellular Immune Response Influenza Vaccine</brief_title>
	<detailed_description>Inclusion criterion : - RA patient - Above age 18 - Treated tocilizumab least 3 month Exclusion criterion : -egg allergy Design study : - Patients control vaccinate sesaonal influenza . Blood take day vaccination 4 week . PBMC isolation The PBMCs bere isolate heparinized venous blood density gradient centrifugation Lymphoprep ( Axis-Shield , Oslo , Norway ) immediately blood drawn . The cell count suspend RPMI 1640 supplement heat-inactivated 10 % fetal calf serum , penicillin 100U/ml , streptomycin 0.1 mg/ml , 2 mM L-glutamine ( Biological Industries , Israel ) . IFN-gamma secretion PBMCs IFN-gamma secretion level measure ELISA supernatant PBMCs stimulate either influenza antigen mixture SEB , leave untreated . Granzyme B activity assay The PBMCs culture 0.5 ml/well 48-well plate ( 1.8X106 cells/well ) stimulate influenza antigen mix SEB described . The cell lysed lysis buffer ( 150mM NaCl , 15mM Tris , 1 % Triton x100 ) , store -760C . Granzyme B activity measure accord protocol describe Gijzen et al . [ 13 ] . Briefly , frozen cell lysates subject three freeze/thaw cycle enable release Granzyme B. Recombinant Granzyme B standard ( Enzo Life Sciences International , Inc. , PA ) cell lysates added duplicate 96-well plate ( 20 µl/well ) . The reaction start upon addition 80 μl substrate solution contain 400 μM Ac-IEPD-pNA substrate ( Calbiochem , Darmstadt , Germany ) assay buffer ( 100mM HEPES pH 7.5 , 10 % ( w/v ) , sucrose , 0.1 % ( w/v ) CHAPS , 10 mM DTT ( Sigma Aldrich , Rehovot , Israel ) . The plate seal , cover incubated dark humidify chamber 370C 20 h. After incubation , plate read 405 nm . Granzyme B unit calculate use 4th order polynominal curve log ( concentration ) −log ( absorbance ) plot , correct protein concentration BCA protein assay ( Thermo Scientific , IL ) . The humoral response The antibody response measure HI test accord standard WHO procedure previously describe [ 14 ] . The titer antiserum show inhibition record 1/10 . Humoral response define either fourfold great rise titer HI antibody , rise non-protective baseline level ( &lt; 1/40 ) 1/40 ) . Geometric mean titer antibody wull calculate assess immunity whole group .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Rheumatoid Arthritis patient treat Tocilizumab least 3 month Above age 18 Allergy egg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Rheumatoid arthritis</keyword>
	<keyword>Tocilizumab</keyword>
	<keyword>Seasonal influenza vaccine</keyword>
</DOC>